Results 281 to 290 of about 12,785,139 (351)

Ex vivo evaluation of the effect of plasma-derived factor VIII/von Willebrand factor in patients with severe hemophilia A on emicizumab prophylaxis. [PDF]

open access: yesClin Exp Med
Raventós A   +9 more
europepmc   +1 more source

Real-world use of recombinant porcine sequence factor VIII in the treatment of acquired hemophilia A: EU PASS. [PDF]

open access: yesTher Adv Hematol
Miesbach W   +11 more
europepmc   +1 more source

Efanesoctocog Alfa versus Standard and Extended Half-Life Factor VIII Prophylaxis in Adolescent and Adult Patients with Haemophilia A without Inhibitors. [PDF]

open access: yesAdv Ther
Klamroth R   +9 more
europepmc   +1 more source

Studies on the Characterization of Factor VIII and a Co-factor VIII

Thrombosis and Haemostasis, 1974
SummaryFactor VIII occurs in the body in two different forms. In lymph factor VIII is bound to chylomicra. In plasma, factor VIII is bound to a protein.After delipidation of chylomicra we obtained a glycoprotein with a high polysaccharide content and a molecular weight of approx.
H. L. M. A Vandenbussche-Scheffers   +4 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy